About half of all cancer patients show a syndrome of cachexia, characterized by anorexia
and loss of adipose tissue and skeletal muscle mass. Cachexia can have a profound impact …

It is estimated that half of all patients with cancer eventually develop a syndrome of
cachexia, with anorexia and a progressive loss of adipose tissue and skeletal muscle mass …

It is appreciated widely by clinicians that significant malnutrition accompanies malignant
processes in approximately 50% of patients and eventually leads to severe wasting which …

Cachexia is a multifactorial process of skeletal muscle and adipose tissue atrophy resulting
in progressive weight loss. It is associated with poor quality of life, poor physical function …

Patients with cancer frequently experience unintended weight loss due to gastrointestinal
(GI) dysfunction caused by the malignancy or treatment of the malignancy. However, others …

Cancer cachexia is a metabolic syndrome that can be present even in the absence of weight
loss ('precachexia'). Cachexia is often compounded by pre-existing muscle loss, and is …

The progressive deterioration in nutrition status frequently seen in cancer patients is often
referred to as cancer cachexia. Unlike starvation, in which fat stores from adipose are …

Cancer cachexia is a multifactorial syndrome characterized by a progressive loss of skeletal
muscle mass, along with adipose tissue wasting, systemic inflammation and other metabolic …

Cancer-associated cachexia is a disorder characterized by loss of body weight with specific
losses of skeletal muscle and adipose tissue. Cachexia is driven by a variable combination …

Cancer cachexia is a multifactorial syndrome characterized by skeletal muscle loss leading
to progressive functional impairment. Despite the ubiquity of cachexia in clinical practice …